Book Description
Despite recent advances in surgery, chemo and radiation therapy, the incidence and death rate for pancreatic cancer continues to rise. Now estimated to be the fourth leading cause of cancer death in the US, less than 2% of patients survive 5 years - the lowest of any tumor type. Despite the recent elucidation of several important oncogenes, tumor suppressor genes, and cell cycle regulators in other malignancies, such studies in pancreatic cancer have been limited, with few details provided on their clinical significance. The Editors of this book, con-cerned with this paucity of information and the difficulties facing pancreas cancer researchers brought together a select group of experts from each major clinical and science field related to pancreatic cancer to review their research and clinical work, and prepare chapters for this book based on their collective discussions and experience. They present the most important findings and issues in pancreatic cancer research and management today, covering major areas of concern to pathologists, surgeons, oncologists and molecular biologists.
